| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $106.4M | +18.0% |
| Cost of Revenue | $15.7M | +50.6% |
| Gross Profit | $90.7M | +13.8% |
| R&D Expense | $13.6M | +9.5% |
| SG&A Expense | $29.0M | +15.5% |
| Operating Income | -$59.6M | -15.4% |
| Interest Expense | $2.8M | -47.5% |
| Income Tax | $0 | — |
| Net Income | -$61.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.7M | -67.3% |
| Accounts Receivable | $20.7M | +45.1% |
| Inventory | $17.3M | +50.3% |
| Current Assets | $137.6M | -21.8% |
| Total Assets | $157.6M | -17.3% |
| Current Liabilities | $21.2M | +25.4% |
| Long-term Debt | $35.2M | +0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.7M | -5.4% |
| Capital Expenditures | $9.5M | +48.8% |
| Investing Cash Flow | -$2.8M | -105.5% |
| Financing Cash Flow | $2.2M | +228.4% |
| Free Cash Flow | -$51.2M | -11.4% |
| -8.3% |
| EPS (Basic) | -$1.79 | -4.7% |
| EPS (Diluted) | -$1.79 | -4.7% |
| Total Liabilities |
| $59.3M |
| +5.6% |
| Stockholders' Equity | $98.3M | -26.9% |